Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

681
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
681
Inflammatory Response01:28

Inflammatory Response

16.6K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.6K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

7.7K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
7.7K
Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Group Therapy01:26

Group Therapy

423
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
423
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

16.3K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproductive Lifespan and Adult-Onset Bronchiectasis in U.S. Postmenopausal Women: An Investigation of the Women's Health Initiative Cohort.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2026
Same author

In Pursuit of Excellence: The Past, Present, and Future of Quality Improvement in Pneumonia.

Clinics in chest medicine·2026
Same author

Cystic Fibrosis Transmembrane Conductance Regulator Mutations and Potential Associations With Increased Rates of Pulmonary Infections Among Patients from the US Bronchiectasis and NTM Research Registry.

Chest·2026
Same author

Association of Chronic Rhinosinusitis and <i>Pseudomonas Aeruginosa</i> in Sputum of Patients With Non-Cystic Fibrosis Bronchiectasis.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2026
Same author

Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trial.

Respiratory investigation·2026
Same author

The Bronchiectasis and Non-Tuberculous Mycobacterial Care Center Network: Improving Access and Quality of Care.

Chest·2026

Related Experiment Video

Updated: Jan 29, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

8.1K

Anti-inflammatory therapies for bronchiectasis.

Jennifer Bautista1, Mark L Metersky2

  • 1Associate Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Connecticut Health.

Current Opinion in Infectious Diseases
|January 27, 2026
PubMed
Summary
This summary is machine-generated.

Anti-inflammatory treatments are crucial for managing bronchiectasis, a chronic lung condition. New therapies like brensocatib show promise in reducing exacerbations and improving lung function and quality of life.

Keywords:
bronchiectasisdipeptidyl peptidase-1 inhibitormacrolidesneutrophilic inflammation

More Related Videos

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.0K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.9K

Related Experiment Videos

Last Updated: Jan 29, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

8.1K
Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.0K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.9K

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Inflammatory Diseases

Background:

  • Bronchiectasis involves chronic airway inflammation and infection, leading to progressive lung damage.
  • This condition significantly impacts patients' quality of life and socioeconomic well-being.
  • Inflammation is a key driver of bronchiectasis progression.

Purpose of the Study:

  • To review current anti-inflammatory treatment options for bronchiectasis.
  • To discuss the benefits and potential side effects of these therapies.
  • To highlight recent advancements in bronchiectasis pharmacotherapy.

Main Methods:

  • Literature review of anti-inflammatory treatments for bronchiectasis.
  • Analysis of clinical trial data for novel therapies.
  • Evaluation of treatment guidelines and common clinical practices.

Main Results:

  • Inhaled corticosteroids are commonly used but may worsen outcomes in some patients.
  • Macrolides can decrease exacerbation frequency and improve quality of life.
  • Brensocatib, a DPP-1 inhibitor, demonstrated significant benefits in a Phase 3 trial, including reduced exacerbations and improved lung function, and is now FDA-approved.

Conclusions:

  • Anti-inflammatory therapy is an essential part of bronchiectasis management.
  • Emerging treatments offer improved outcomes for patients with bronchiectasis.